Tobacco Screening and Treatment during Outpatient Urology Office Visits in the United States
被引:13
|
作者:
Bernstein, Ari P.
论文数: 0引用数: 0
h-index: 0
机构:
NYU, Dept Urol, Sch Med, New York, NY 10016 USANYU, Dept Urol, Sch Med, New York, NY 10016 USA
Bernstein, Ari P.
[1
]
Bjurlin, Marc A.
论文数: 0引用数: 0
h-index: 0
机构:
Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Urol, Chapel Hill, NC 27515 USANYU, Dept Urol, Sch Med, New York, NY 10016 USA
Bjurlin, Marc A.
[4
]
Sherman, Scott E.
论文数: 0引用数: 0
h-index: 0
机构:
NYU, Dept Populat Hlth, Sch Med, New York, NY 10016 USA
VA New York Harbor Healthcare Syst, New York, NY USANYU, Dept Urol, Sch Med, New York, NY 10016 USA
Sherman, Scott E.
[2
,3
]
Makarov, Danil, V
论文数: 0引用数: 0
h-index: 0
机构:
NYU, Dept Urol, Sch Med, New York, NY 10016 USA
NYU, Dept Populat Hlth, Sch Med, New York, NY 10016 USA
VA New York Harbor Healthcare Syst, New York, NY USANYU, Dept Urol, Sch Med, New York, NY 10016 USA
Makarov, Danil, V
[1
,2
,3
]
Rogers, Erin
论文数: 0引用数: 0
h-index: 0
机构:
NYU, Dept Populat Hlth, Sch Med, New York, NY 10016 USANYU, Dept Urol, Sch Med, New York, NY 10016 USA
Rogers, Erin
[2
]
Matulewicz, Richard S.
论文数: 0引用数: 0
h-index: 0
机构:
NYU, Dept Urol, Sch Med, New York, NY 10016 USA
NYU, Dept Populat Hlth, Sch Med, New York, NY 10016 USA
VA New York Harbor Healthcare Syst, New York, NY USANYU, Dept Urol, Sch Med, New York, NY 10016 USA
Matulewicz, Richard S.
[1
,2
,3
]
机构:
[1] NYU, Dept Urol, Sch Med, New York, NY 10016 USA
[2] NYU, Dept Populat Hlth, Sch Med, New York, NY 10016 USA
[3] VA New York Harbor Healthcare Syst, New York, NY USA
[4] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Urol, Chapel Hill, NC 27515 USA
Purpose: Tobacco use is a causative or exacerbating risk factor for benign and malignant urological disease. However, it is not well known how often urologists screen for tobacco use and provide tobacco cessation treatment at the population level. We sought to evaluate how often urologists see patients for tobacco-related diagnoses in the outpatient setting and how often these visits include tobacco use screening and treatment. Materials and Methods: We used the National Ambulatory Medical Care Survey public use files for the years 2014-2016 to identify all outpatient urology visits with adults 18 years old or older. Clinic visit reasons were categorized according to diagnoses associated with the encounter: all urological diagnoses, a tobaccorelated urological condition or a urological cancer. Our primary outcome was the percentage of visits during which tobacco screening was reported. Secondary outcomes included reported delivery of cessation counseling and provision of cessation pharmacotherapy. Results: We identified 4,625 unique urological outpatient encounters, representing a population-weighted estimate of 63.9 million visits over 3 years. Approximately a third of all urology visits were for a tobacco-related urological diagnosis and 15% were for urological cancers. An estimated 1.1 million visits over 3 years were with patients who identified as current tobacco users. Of all visits, 70% included tobacco screening. However, only 7% of visits with current smokers included counseling and only 3% of patients were prescribed medications. No differences in screening and treatment were observed between visit types. Conclusions: Urologists regularly see patients for tobacco-related conditions and frequently, although not universally, screen patients for tobacco. However, urologists rarely offer counseling or cessation treatment. These findings may represent missed opportunities to decrease the morbidity associated with tobacco use.
机构:
Stanford Univ, Program Prevent Outcomes & Practices, Stanford Prevent Res Ctr, Stanford, CA 94305 USAStanford Univ, Program Prevent Outcomes & Practices, Stanford Prevent Res Ctr, Stanford, CA 94305 USA
Ma, J
Lee, KV
论文数: 0引用数: 0
h-index: 0
机构:
Stanford Univ, Program Prevent Outcomes & Practices, Stanford Prevent Res Ctr, Stanford, CA 94305 USAStanford Univ, Program Prevent Outcomes & Practices, Stanford Prevent Res Ctr, Stanford, CA 94305 USA
Lee, KV
Stafford, RS
论文数: 0引用数: 0
h-index: 0
机构:
Stanford Univ, Program Prevent Outcomes & Practices, Stanford Prevent Res Ctr, Stanford, CA 94305 USAStanford Univ, Program Prevent Outcomes & Practices, Stanford Prevent Res Ctr, Stanford, CA 94305 USA
机构:
VA New York Harbor Healthcare Syst, New York, NY USAVA New York Harbor Healthcare Syst, New York, NY USA
Matulewicz, Richard S.
Bassett, Jeffrey C.
论文数: 0引用数: 0
h-index: 0
机构:
Hoag Hlth Network, Hoag Urol Oncol, Newport Beach, CA USAVA New York Harbor Healthcare Syst, New York, NY USA
Bassett, Jeffrey C.
Kwan, Lorna
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USAVA New York Harbor Healthcare Syst, New York, NY USA
Kwan, Lorna
Sherman, Scott E.
论文数: 0引用数: 0
h-index: 0
机构:
VA New York Harbor Healthcare Syst, New York, NY USA
NYU, Dept Populat Hlth, New York, NY USAVA New York Harbor Healthcare Syst, New York, NY USA
Sherman, Scott E.
McCarthy, William J.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif Los Angeles, Dept Hlth Policy & Management, Fielding Sch Publ Hlth, Los Angeles, CA USA
Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USAVA New York Harbor Healthcare Syst, New York, NY USA
McCarthy, William J.
Seigal, Christopher S.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USAVA New York Harbor Healthcare Syst, New York, NY USA
Seigal, Christopher S.
Gore, John L.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Washington, Sch Med, Dept Urol, Seattle, WA 98195 USAVA New York Harbor Healthcare Syst, New York, NY USA
机构:
Peoples Hosp Jianyang City, Dept Gen Practice, Jianyang, Peoples R ChinaPeoples Hosp Jianyang City, Dept Gen Practice, Jianyang, Peoples R China
Liu, Yiheng
Dai, Weiran
论文数: 0引用数: 0
h-index: 0
机构:
Chongqing Med Univ, Affiliated Hosp 2, Dept Cardiol, 76 Linjiang Rd, Chongqing 400010, Peoples R ChinaPeoples Hosp Jianyang City, Dept Gen Practice, Jianyang, Peoples R China